Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach

NCT07316296 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT07316296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07316296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Lead sponsor
Radboud University Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

freezing of gait, freezing of gait symptoms in parkinson disease, parkinson's disease (pd)